Psorolin B: a formulation with synchronized, synergistic scooping of botanicals and associated exodus therapeutic benefit to psoriasis
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20214918Keywords:
Psoriasis, Pro-inflammatory mediators, Psorolin B, Triggers of psoriasisAbstract
Background: Psoriasis is an auto-inflammatory disease condition, with the clinical symptoms of scaling, inflammation and itching. This condition is triggered by external and internal factors such as environment, seasons and free radicles etc. Psorolin B is a proprietary Siddha Medicine indicated for the reduction in the psoriatic symptoms and also for inhibiting the various triggers of psoriasis
Methods: In the present paper, the formulation is evaluated for its anti-oxidant effect, anti-glycation effect, enzymatic activity reduction i.e., elastase, collagenase, lipoxygenase and reduction in COX1 and COX 2 by following the standard methods.
Results: In the present paper, the formulation is evaluated for its anti-oxidant effect, anti-glycation effect, enzymatic activity reduction i.e., elastase, collagenase, lipoxygenase and reduction in COX1 and COX 2 by following the standard methods. The study results show that the product is able to reduce- free radicle scavenging activity, advanced glycation end products, elastase, collagenase, lipoxygenase and COX1 and COX 2
Conclusions: The study results prove that this product can control the pro-inflammatory mediators by inhibiting the triggering factors like free radicles and advanced glycation end products. This also play a major role in inhibiting the elastase and collagenase that helps in reducing the cell cycle turn over. Complete details of the study are explained the paper.
Metrics
References
Huang YW, Tsai TF. Remission Duration and Long-Term Outcomes in Patients with Moderate-to-Severe Psoriasis Treated by Biologics or Tofacitinib in Controlled Clinical Trials: A 15-Year Single-Center Experience. Dermatol therapy, 2019;9(3):553-69.
Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012;26(2):3-11.
Lin X, Huang T. 2016, Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res. 2016;50(6):585-95.
Wiedow O, Wiese F, Streit V, Kalm C, Chris E. Lesional Elastase Activity in Psoriasis, Contact Dermatitis, and Atopic Dermatitis. J investigative Dermatol. 1992;99(3):306-9.
Uva L, Miguel D, Pinheiro C, Antunes J, Cruz D, Ferreira J, Filipe P. Mechanisms of action of topical corticosteroids in psoriasis. Int j endocrinol. 2012;561018.
Metzman MD. Topical 5-lipoxygenase inhibitors in the treatment of psoriasis. J Dermatol Treat. 2020;2(3):117-20
Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A. Safety of Cyclooxygenase 2 Inhibitors and Increased Leukotriene Synthesis in Chronic Idiopathic Urticaria with Sensitivity to Nonsteroidal Anti-inflammatory Drugs. Arch Dermatol. 139(12):1577-82.
Sun S, Wang Y, Wu A. Influence Factors of the Pharmacokinetics of Herbal Resourced Compounds in Clinical Practice. Evidence-Based Complementary Alternative Med. 2019;1983780:16
Shenefelt PD. Herbal Treatment for Dermatologic Disorders. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis. 2011;18.
Aruna V, Amruthavalli GV, Gayathri R. Psorolin B-A new ‘taxon’ in the treatment of psoriasis and the science of electrochemical homeostasis. World j pharmac res. 2021;10(8):554-9.
Amruthavalli GV, Aruna V, Gayathri R. Botanical warriors to combat pro-inflammation mediators-A way forward for Psoriasis management. Int Invention Scientific J. 2021;05(9):21-4.
Importance of thermo, hydro and lipid chemistry of psorolin b and its treatment significance in psoriasis. Eur j pharmac med res. 2021;8:7.
Aruna V, Amruthavalli GV, Gayathri R. Use of cosmetic products for treating certain diseases-Know the science. J Cosmet Dermatol. 2019;18:221-5.
Scientific and clinical proof for the use of a cell repair cream formulation for Psoriasis. MST International J Pharma Sci Pharma. 2002;1(1):4-12.
Downloads
Published
How to Cite
Issue
Section
